The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Lack of Neointimal Proliferation After Implantation of Sirolimus-Coated Stents in Human Coronary Arteries: A Quantitative Coronary Angiography and Three-Dimensional Intravascular Ultrasound Study
Abstract
Background —Restenosis remains an important limitation of interventional cardiology. Therefore, we aimed to determine the safety and efficacy of sirolimus (a cell-cycle inhibitor)-coated BX Velocity stents. Methods and Results —Thirty patients with angina pectoris were electively treated with 2 different formulations of sirolimus-coated stents (slow release [SR], n=15, and fast release [FR], n=15). All stents were successfully delivered, and patients were discharged without clinical complications. Independent core laboratories analyzed angiographic and 3D volumetric intravascular ultrasound data (immediately after procedure and at 4-month follow-up). Eight-month clinical follow-up was obtained for all patients. There was minimal neointimal hyperplasia in both groups (11.0±3.0% in the SR group and 10.4±3.0% in the FR group, P =NS) by ultrasound and quantitative coronary angiography (in-stent late loss, 0.09±0.3 mm [SR] and −0.02±0.3 mm [FR]; in-lesion late loss, 0.16±0.3 mm [SR] and −0.1±0.3 mm [FR]). No in-stent or edge restenosis (diameter stenosis ≥50%) was observed. No major clinical events (stent thrombosis, repeat revascularization, myocardial infarction, or death) had occurred by 8 months. Conclusions —The implantation of sirolimus-coated BX Velocity stents is feasible and safe and elicits minimal neointimal proliferation. Additional placebo-controlled trials are required to confirm these promising results.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Catheter-Based Radiotherapy to Inhibit Restenosis after Coronary Stenting
Teirstein, P. S., Massullo, V., Jani, S., Popma, J. J., Mintz, G. S., Russo, R. J., Schatz, R. A., Guarneri, E. M., Steuterman, S., Morris, N. B., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706123362402 · Cited by 942
Self-citationGroth, C. G., Bäckman, L., Morales, J.-M., Calne, R., Kreis, H., Lang, P., Touraine, J.-L., Claesson, K., Campistol, J. M., Durand, D., et al. (1999) · Transplantation · doi:10.1097/00007890-199904150-00017 · Cited by 878
van der Giessen, W. J., Lincoff, A. M., Schwartz, R. S., van Beusekom, H. M. M., Serruys, P. W., Holmes, D. R., Ellis, S. G., & Topol, E. J. (1996) · Circulation · doi:10.1161/01.cir.94.7.1690 · Cited by 852
Self-citationRapamycin-FKBP Inhibits Cell Cycle Regulators of Proliferation in Vascular Smooth Muscle Cells
Marx, S. O., Jayaraman, T., Go, L. O., & Marks, A. R. (1995) · Circulation Research · doi:10.1161/01.res.76.3.412 · Cited by 599
Rapamycin inhibits vascular smooth muscle cell migration.
Poon, M., Marx, S. O., Gallo, R., Badimon, J. J., Taubman, M. B., & Marks, A. R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119038 · Cited by 511
Gallo, R., Padurean, A., Jayaraman, T., Marx, S., Roque, M., Adelman, S., Chesebro, J., Fallon, J., Fuster, V., Marks, A., et al. (1999) · Circulation · doi:10.1161/01.cir.99.16.2164 · Cited by 490
Late Coronary Occlusion After Intracoronary Brachytherapy
Costa, M. A., Sabaté, M., van der Giessen, W. J., Kay, I. P., Cervinka, P., Ligthart, J. M. R., Serrano, P., Coen, V. L. M. A., Levendag, P. C., & Serruys, P. W. (1999) · Circulation · doi:10.1161/01.cir.100.8.789 · Cited by 389
Self-citationFrontiers in Interventional Cardiology
Topol, E. J., & Serruys, P. W. (1998) · Circulation · doi:10.1161/01.cir.98.17.1802 · Cited by 247
Self-citationLocal drug delivery for the prevention of restenosis. Fact, fancy, and future.
Lincoff, A. M., Topol, E. J., & Ellis, S. G. (1994) · Circulation · doi:10.1161/01.cir.90.4.2070 · Cited by 171
Rapamycin Reverses Chronic Graft Vascular Disease in a Novel Cardiac Allograft Model
Poston, R. S., Billingham, M., Hoyt, E. G., Pollard, J., Shorthouse, R., Morris, R. E., & Robbins, R. C. (1999) · Circulation · doi:10.1161/01.cir.100.1.67 · Cited by 158
Innovations in acrylic bone cement and application equipment
Kindt‐Larsen, T., Smith, D. B., & Jensen, J. S. (1995) · Journal of Applied Biomaterials · doi:10.1002/jab.770060111 · Cited by 111
Burke, S. E., Lubbers, N. L., Chen, Y., Hsieh, G. C., Mollison, K. W., Luly, J. R., & Wegner, C. D. (1999) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199906000-00001 · Cited by 100
Revell, P. A., Braden, M., & Freeman, M. A. R. (1998) · Biomaterials · doi:10.1016/s0142-9612(97)00118-x · Cited by 91
Lafont, A., & Faxon, D. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00109-6 · Cited by 75
Cited by
Moses, J. W., Leon, M. B., Popma, J. J., Fitzgerald, P. J., Holmes, D. R., O'Shaughnessy, C., Caputo, R. P., Kereiakes, D. J., Williams, D. O., Teirstein, P. S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035071 · Cited by 4,224
Self-citationMorice, M.-C., Serruys, P. W., Sousa, J. E., Fajadet, J., Ban Hayashi, E., Perin, M., Colombo, A., Schuler, G., Barragan, P., Guagliumi, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012843 · Cited by 4,033
Self-citationWRITING COMMITTEE MEMBERS, Smith, S. C., Feldman, T. E., Hirshfeld, J. W., Jacobs, A. K., Kern, M. J., King, S. B., Morrison, D. A., O’Neill, W. W., Schaff, H. V., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.170815 · Cited by 2,218
Virmani, R., Guagliumi, G., Farb, A., Musumeci, G., Grieco, N., Motta, T., Mihalcsik, L., Tespili, M., Valsecchi, O., & Kolodgie, F. D. (2004) · Circulation · doi:10.1161/01.cir.0000116202.41966.d4 · Cited by 1,469
Late Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting Stents
Pfisterer, M., Brunner-La Rocca, H. P., Buser, P. T., Rickenbacher, P., Hunziker, P., Mueller, C., Jeger, R., Bader, F., Osswald, S., & Kaiser, C. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.10.026 · Cited by 1,303
Metadata
- Authors
- Sousa, J. E., Costa, M. A., Abizaid, A., Abizaid, A. S., Feres, F., Pinto, I. M. F., Seixas, A. C., Staico, R., Mattos, L. A., Sousa, A. G. M. R., Falotico, R., Jaeger, J., Popma, J. J., & Serruys, P. W.
- Venue
- Circulation
- Published
- 2001-01-16
- Volume
- 103
- Issue
- 2
- Pages
- 192-195
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1998004031
- Cited by
- 793
- References
- 14
- FWCI
- 96.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.